SINOPHARM TECH (08156) issues profit warning, expecting annual loss attributable to shareholders of HK$9 million to HK$11 million

SINOPHARM TECH (08156) issued an announcement that the Group expects to record a loss attributable to owners of the Company of between HK$9 million and HK$11 million for the year ended 30 June 2026, as compared to a loss attributable to owners of the Company of approximately HK$0.8 million for the year ended 30 June 2025. The Board considers that the increase in loss attributable to owners of the Company during the Reporting Period was primarily due to (i) a significant year-on-year decline in revenue from the Group's supply chain services business; and (ii) an increase in selling and distribution expenses during the Reporting Period compared to the same period in 2025, which was attributable to increased product promotion costs.